You are here

Article info

Article menu

Download PDFPDF

XML
Chronic obstructive pulmonary disease
Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations

Authors

  • Marjolein Brusse-Keizer Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, The Netherlands PubMed articlesGoogle scholar articles
  • Paul VanderValk Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, The Netherlands PubMed articlesGoogle scholar articles
  • Ron Hendrix Regional Laboratory of Public Health, Enschede, The Netherlands Department of Medical Microbiology, University Medical Centre Groningen, and University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Huib Kerstjens Department of Pulmonary Medicine, and Groningen Research Institute for Asthma and COPD (GRIAC), University Of Groningen, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Job van der Palen Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, The Netherlands Department of Research Methodology, Measurement, and Data Analysis, University of Twente, Enschede, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Marjolein Brusse-Keizer; m.brusse-keizer{at}mst.nl
View Full Text

Citation

Brusse-Keizer M, VanderValk P, Hendrix R, et al
Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
BMJ Open Respiratory Research 2014;1:e000052. doi: 10.1136/bmjresp-2014-000052

Publication history

  • Received June 10, 2014
  • Revised November 13, 2014
  • Accepted November 16, 2014
  • First published December 30, 2014.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/